Cite
HARVARD Citation
Sung, P. et al. (2018). The Five-Year Clinical and Angiographic Follow-Up Outcomes of Intracoronary Transfusion of Circulation-Derived CD34+ Cells for Patients With End-Stage Diffuse Coronary Artery Disease Unsuitable for Coronary Intervention—Phase I Clinical Trial. Critical care medicine. 46 (5), p. . [Online].